Psychosis associated with anti-N-methyl-d-aspartate receptor antibodies

CNS Spectrums

Volumn 13, Issue 8, 2008, Pages 699-703

  Nasky, Kevin M ^a   Knittel, Douglas R ^a   Manos, Gail H ^a  

^a NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BENZATROPINE MESILATE; CORTICOSTEROID; ETIRACETAM; HALOPERIDOL; IMMUNOGLOBULIN; LORAZEPAM; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; PHENYTOIN; QUETIAPINE; VALPROIC ACID;

ADULT; AGITATION; AMNESIA; ARTICLE; ATHETOSIS; AUTONOMIC DYSFUNCTION; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DELUSION; DISORIENTATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSKINESIA; ENCEPHALITIS; FEMALE; HEADACHE; HUMAN; HYPERAMMONEMIA; HYPERKINESIA; INVOLUNTARY MOVEMENT; LOADING DRUG DOSE; MEMORY DISORDER; MIGRAINE; MINI MENTAL STATE EXAMINATION; PRESYNCOPE; PRIORITY JOURNAL; PSYCHOSIS; TACHYCARDIA; TONIC CLONIC SEIZURE;

EID: 51749113530     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S109285290001378X     Document Type: Article

References (17)

1. Dalmau J, Bataller L. Limbic encephalitis: the new cell membrane antigens and a proposal of clinical-immunological classification with therapeutic implications [Spanish]. Neurologia. 2007;22:526-537.
2. Corsellis JA, Goldberg GJ, Norton AR. "Limbic encephalitis" and its association with carcinoma. Brain. 1968;91:481-496.
3. Alamowitch S, Graus F, Uchuya M, Reñé R, Bescansa E, Delattre JY. Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain. 1997;120 (pt 6):923-928.
4. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JIB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123(pt 7):1481-1494.
5. Iizuka T, Sakai F, Ide T et al. Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology. 2008;70:504-511.
6. Kataoka H, Dalmau J, Ueno S. Paraneoplastic encephalitis associated with ovarian teratoma and N-methyl-D-aspartate receptor antibodies. Eur J Neurol. 2008;15:e5-e6.
7. Seki M, Suzuki S, Iizuka T, et al. Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry. 2008;79:324-326.
8. Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25-36.
9. Graus F, Dalmau J. Paraneoplastic neurological syndromes: diagnosis and treatment. Curr Opin Neurol. 2007;20:732-737.
10. Linke R, Schroeder M, Hemberger T, Voltz R. Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis. Neurology. 2004;63:282-286.
11. Linke R, Voltz R. FDG-pet in paraneoplastic syndromes. Recent Results Cancer Res. 2008;170:203-211.
12. Sansing LH, Tüzün E, Ko MW, Baccon J, Lynch DR, Dalmau J. A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol. 2007:3:291-296.
13. Mori H, Mishina M. Structure and function of the NMDA receptor channel. Neuropharmacology. 1995;34:1219-1237.
14. Waxman EA, Lynch DR. N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist. 2005;11:37-49.
15. Schatzberg AF, Nemeroff CB, eds. The American Psychiatric Publishing Textbook of Psychopharmacology. 3rd ad. Washington, DC: American Psychiatric Publishing; 2003.
16. Luby ED, Gottlieb JS, Cohen BD, Rosenbaum G, Domino EF Model psychoses and schizophrenia. Am J Psychiatry. 1962;119:61-67.
17. Rujescu D, Bender A, Keck M, et al. A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry. 2006;59:721-729.